Conservative management of patients with cerebrospinal fluid shunt infections

被引:15
|
作者
Brown, EM
Edwards, RJ
Pople, IK
机构
[1] Frenchay Hosp, Dept Med Microbiol, Bristol BS16 1LE, Avon, England
[2] Frenchay Hosp, Dept Neurosurg, Bristol BS16 1LE, Avon, England
关键词
adverse event; infection; outpatient therapy; ventricular access device; ventriculoperitoneal shunt;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: In patients with cerebrospinal fluid (CSF) shunt infection, removal of the shunt and antibiotic administration is the current standard of care. In 1986, we developed a protocol for the conservative management of patients with infected but functioning shunts. Treatment was based on the administration of a combination of intraventricular and systemic antibiotics. Intraventricular antibiotics were instilled via a separate access device. The purpose of this report is to describe our experience with this therapeutic intervention. METHODS: An observational study of all patients treated for CSF shunt infection between 1986 and 2003 was undertaken. Cure was defined by sterile CSF after completion of therapy and sterile shunt components at next revision or long-term freedom from recurrent infection (follow-up period, 6-88 mo). RESULTS: In total, 43 of 122 patients with CSF shunt infections were treated conservatively according to our protocol. Overall, 84% of these patients were cured, with a 92% success rate for patients with infections caused by bacteria other than Staphylococcus aureus. This included 30 coagulase-negative staphylococcal infections, of which two were treatment failures. We abandoned conservative treatment of patients with Staphylococcus aureus infections after early experience demonstrated that the success rate (four treatment failures in seven patients) was markedly lower than that for other pathogens. During the treatment and follow-up periods, there were three deaths, two of which were unrelated to shunt infection; treatment failure could not be completely excluded in the remaining patient. There was no toxicity related to intraventricular antibiotic administration. The incidence of shunt blockage among patients who were treated conservatively was not significantly different from that among a large cohort of patients with uninfected shunts. Ten patients received part of their courses of treatment as outpatients. CONCLUSION: The success rate of conservative management of patients with CSF shunt infections caused by coagulase-negative staphylococci is comparable with those in the published literature for patients treated conventionally. This form of management avoids surgical intervention, with its attendant risks, and is safe.
引用
收藏
页码:657 / 664
页数:8
相关论文
共 50 条
  • [41] Improved ventriculoatrial shunt for cerebrospinal fluid diversion after multiple ventriculoperitoneal shunt failures
    Zhang, Jiqing
    Qu, Chuncheng
    Wang, Zhigang
    Wang, Chengwei
    Ding, Xuan
    Pan, Shun
    Ji, Yong
    SURGICAL NEUROLOGY, 2009, 72 : S29 - S34
  • [42] Proprionibacterium acnes infections of cerebrospinal fluid shunts
    T. P. Thompson
    A. Leland Albright
    Child's Nervous System, 1998, 14 : 378 - 380
  • [43] Proprionibacterium acnes infections of cerebrospinal fluid shunts
    Thompson, TP
    Albright, AL
    CHILDS NERVOUS SYSTEM, 1998, 14 (08) : 378 - 380
  • [44] Cerebrospinal fluid shunt infection in children: efficiency of management protocol, rate of persistent shunt colonization, and significance of 'off-antibiotics' trial
    Wang, KC
    Lee, HJ
    Sung, JN
    Cho, BK
    CHILDS NERVOUS SYSTEM, 1999, 15 (01) : 38 - 43
  • [45] Applied deep learning in neurosurgery: identifying cerebrospinal fluid (CSF) shunt systems in hydrocephalus patients
    Rhomberg, Thomas
    Trivik-Barrientos, Felipe
    Hakim, Arsany
    Raabe, Andreas
    Murek, Michael
    ACTA NEUROCHIRURGICA, 2024, 166 (01)
  • [46] Reducing the incidence of infection in pediatric cerebrospinal fluid shunt operations
    K. Rotim
    P. Miklic
    J. Paladino
    A. Melada
    M. Marcikic
    M. Scap
    Child’s Nervous System, 1997, 13 : 584 - 587
  • [47] Cerebrospinal fluid shunt infection: a prospective study of risk factors
    Kulkarni, AV
    Drake, JM
    Lamberti-Pasculli, M
    JOURNAL OF NEUROSURGERY, 2001, 94 (02) : 195 - 201
  • [48] Cerebrospinal fluid shunt infection in children: efficiency of management protocol, rate of persistent shunt colonization, and significance of `off-antibiotics' trial
    K.-C. Wang
    Hoan Jong Lee
    Jung-Nam Sung
    Byung-Kyu Cho
    Child's Nervous System, 1999, 15 : 38 - 43
  • [49] Abdominal Cerebrospinal Fluid Pseudocyst as a Complication of Ventriculoperitoneal Shunt Placement
    Achufusi, Ted George O.
    Chebaya, Philip
    Rawlins, Sekou
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (07)
  • [50] Detailed standardized protocol to prevent cerebrospinal fluid shunt infection
    Okamura, Yuma
    Maruyama, Keisuke
    Fukuda, Shin
    Horikawa, Hiroshi
    Sasaki, Nobuyoshi
    Noguchi, Akio
    Nagane, Motoo
    Shiokawa, Yoshiaki
    JOURNAL OF NEUROSURGERY, 2020, 132 (03) : 755 - 759